Withdrawal of terodiline hydrochloride.
Holt
P E
PE
D000818:Animals; D002082:Butylamines / Q000009:adverse effects* / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D010276:Parasympatholytics / Q000009:adverse effects* / Q000627:therapeutic use; D014555:Urination Disorders / Q000188:drug therapy / Q000662:veterinary*
D002082:Butylamines; D010276:Parasympatholytics; C010637:terodiline